Magnesium (Mg 2ϩ ) is the second most abundant intracellular cation after potassium and the fourth most abundant cation of the body after calcium, potassium, and sodium. Mg 2ϩ is involved in hundreds of enzymatic reactions and is essential for life. Mg 2ϩ is an important co-factor for many biologic processes, most of which use ATP. Mg 2ϩ is an essential mineral that is important for bone mineralization, muscular relaxation, neurotransmission, and other cell functions. 1 Extracellular Mg 2ϩ concentration is tightly regulated by the extent of intestinal absorption and renal excretion. Like calcium (Ca 2ϩ ), Mg 2ϩ plays a role in the regulation of parathyroid hormone (PTH) secretion. Hypermagnesemia suppresses the release of PTH. Acute hypomagnesaemia has the opposite effect; however, profound Mg 2ϩ depletion decreases the release of PTH and induces skeletal resistance to PTH and severe hypocalcemia. 2 Consequently, profound Mg 2ϩ deficiency causes tetany, cardiac arrhythmia, and bone instability and encourages renal stone formation. Mg 2ϩ deficiency has also been reported in 20 to 60% of patients in intensive care units (ICU). [3] [4] [5] Mg 2ϩ homeostasis involves the kidney, small bowel, and bone. In the gastrointestinal tract, Mg 2ϩ absorption occurs primarily in the jejunum and ileum by both a passive paracellular mechanism and an active transport process 8, 9 ; however, most evidence suggests that Mg 2ϩ is absorbed mainly by ionic diffusion and "solvent drag" resulting from the bulk flow of water. At low intraluminal concentrations, Mg 2ϩ is absorbed primarily through the active cellular route and, with increasing concentrations, through the paracellular pathway. ; however, most of those patients had renal insufficiency.
The kidney plays a crucial role in the maintenance of Mg 2ϩ balance, and approximately 2 g of Mg 2ϩ is filtered daily by the human kidney and approximately 100 mg appears in the urine. Thus, approximately 95% of the filtered Mg 2ϩ is reabsorbed and 5% is excreted in the urine. At the glomerular membrane, Mg 2ϩ is filtered at the rate of 80% of the total Mg 2ϩ present in the serum. Microperfusion studies by Quamme and Dirks 10 revealed that the proximal tubule is relatively impermeable to Mg 2ϩ . In the adult, the absorption of Mg 2ϩ in this segment is approximately 10 to 15% of the filtered Mg 2ϩ , considerably less than the reabsorption of sodium and Ca. The majority of Mg 2ϩ is reabsorbed in the thick ascending limb of the Henle's loop through paracellular pathways. Approximately 70% of all filtered Mg 2ϩ is reabsorbed in the thick ascending limb. The driving force for Mg 2ϩ reabsorption in this segment of the nephron is the positive transluminal epithelial voltage generated by potassium recycling across the apical membrane. 11 A member of the claudin family of tight junction proteins, paracellin-1, was detected in the thick ascending limb and in the distal tubule. Paracellin-1 is a highly negative charged protein. This negative charge contributes to the cationic selectivity of the reabsorptive paracellular pathway for Ca 2ϩ and Mg
2ϩ
. Mutations in the paracellin-1 gene induces Mg 2ϩ wasting, hypercalciuria, nephrocalcinosis, and renal failure. 12, 13 Recently, mouse studies by Hou et al. 14 recessive or autosomal recessive decreases in intestinal Mg 2ϩ absorption, which seem to be associated with mutations in the TRPM6 gene. Acute pancreatitis can also be associated with hypomagnesemia, similar to the observations of the association between pancreatitis and hypocalcemia. 22 Renal causes of hypomagnesemia are either a primary defect in the tubular reabsorption of Mg 2ϩ or disorders in which tubular sodium reabsorption is impaired. Thus, both loop and thiazide diuretics can inhibit Mg 2ϩ reabsorption, although this effect is usually mild in clinical practice.
Renal Mg 2ϩ wasting is also found in alcoholic patients and seems to be due to alcohol-induced impairment of Mg 2ϩ reabsorption. [23] [24] [25] This effect may augment other potential contributing factors in this clinical setting, including dietary deficiency, pancreatitis, or diarrhea. Several drugs have been associated with urinary Mg 2ϩ wasting, including aminoglycosides, amphotericin B, cisplatin, cyclosporin A, and pentamidine. 26 Renal Mg 2ϩ wasting has also been associated with Gitelman syndrome and in some cases of Bartter syndrome. 27, 28 Renal Mg 2ϩ wasting has also been noted as a result of antibody therapy targeting the EGF receptor. 17, 29 Gitelman syndrome is a form of Mg 2ϩ wasting that is caused by a defect in the gene encoding the thiazide-sensitive sodium chloride transporter, whereas Bartter syndrome is a group of disorders caused by impaired function of the components of the transporter of sodium chloride in the loop of Henle. Hypocalciuria and hypokalemia are commonly seen. Other forms of renal Mg 2ϩ wasting are associated with hypercalciuria, nephrolithiasis, and nephrocalcinosis. This last syndrome is due to mutations in the paracellin-1 gene, which encodes for a tight junction protein that facilitates the paracellular transport of Ca 2ϩ and Mg 2ϩ in the thick ascending limb. Additional inherited causes of Mg 2ϩ wasting have been identified to be due to mutations in the gene encoding the ␥ subunit of Na,K-ATPase. Hypomagnesemia is also common in patients with diabetes and seems to be the result of renal Mg 2ϩ wasting.
TREATMENT OF HYPOMAGNESEMIA
It is well accepted that in cases of severe (Ͻ1 mEq/L in the serum) and symptomatic hypomagnesemia with neuromuscular or neurologic manifestations or cardiac arrhythmias, Mg 2ϩ repletion should be achieved by intravenous administration of 2 g of Mg 2ϩ sulfate in 100 ml of D5W over 5 to 10 min and followed by a continuous infusion of 4 to 6 g/d for 3 to 5 d if renal function is relatively normal. It is important that the cause of the Mg 2ϩ deficiency also be addressed to prevent future recurrences. Maintenance therapy may require oral administration of Mg 2ϩ oxide (400 mg twice daily or three times daily) for as long as the risk factors for Mg 2ϩ deficiency exist. Oral Mg 2ϩ gluconate (500 mg twice daily or three times daily) can also be used. In addition, there are several slow-release Mg 2ϩ preparations. As noted, is also important to address the underlying cause, and if diuretic therapy is being used, consideration should be given to the use of potassium-sparing diuretics such as amiloride, which can increase Mg 2ϩ reabsorption in the cortical collecting duct. Amiloride can also be useful in Gitelman or Bartter syndrome, as well as renal Mg 2ϩ wasting associated with cisplatin. The treatment of patients who have mild hypomagnesemia and are asymptomatic is more problematic. In asymptomatic hospitalized patients with relatively mild reductions in serum Mg 2ϩ (between 1.0 and 1.5 mEq/L)-as often occurs in patients in the ICU settingthe significance of hypomagnesemia is not clear, and it is often associated with other abnormalities such as hypoalbuminemia, hypophosphatemia, and hypokalemia. In such patients, aggressive treatment does not need to be undertaken, and the treatment should be considered in conjunction with the treatment of the associated electrolyte abnormalities and the general management of the patient with attention to his or her nutritional therapy. Measurements of ionized Mg 2ϩ have not helped to define the importance of this issue. It is reasonable, however, to consider the provision of Mg 2ϩ in enteral or parenteral feedings in this patient group as long as they are not eating a normal diet. Although Mg 2ϩ deficiency is associated with worse outcomes in these patients, no controlled trials have assessed whether supplementation would improve clinical outcomes.
Another area in which there is considerable controversy relates to asymptomatic hypomagnesemia, which has been reported to occur in between 13 and 48% of patients with type 2 diabetes. 30 -35 Although it has been suggested that Mg 2ϩ deficiency contributes to the induction of diabetes and its associated complica- , and variations in study population complicate these trials. 30, [37] [38] [39] 
CONCLUSIONS

Mg
2ϩ deficiency continues to be underrecognized and may lead to serious consequences. It should be routinely measured in critically ill patients and in those with conditions that are known to be associated with Mg 2ϩ deficiency.
